Znn3bq.jpeg
ÉÇÍ·´óѧº£Ñó¿ÆÑ§½ÓÊܵ÷¼Á
²é¿´: 561  |  »Ø¸´: 6
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

eveb

ľ³æ (ÕýʽдÊÖ)

[½»Á÷] ´ó¼Ò°ï濴һ϶þÉóÒâ¼û.¼¸¸öÒÉÎÊÇë¸ßÊÖÖ¸µã,лл

ÎÄÕ¾­¹ý³õÉóÈôóÐÞ.´óÐÞºó¾­¶þÉó,Òâ¼ûÈçÏÂ
Reviewer #1: The paper has been clearly improved. However, the effects of bFGF gene silencing on glioma cell proliferation remain rather low.
Minor point: the authors should label the x-axis of the diagram in Fig. 4.

Reviewer #2: The authors have responded to most of the reviewers comments, but serious reservations remain.
The biggest issue is that the effects observed are fairly modest, and do not provide convincing evidence that this approach will lead anywhere in glioma therapy.
This could potentially be rescued by survival studies, or combinations with chemotherapeutics as suggested in the previous round of comments. The use of glioma stem-like cells may also help, as these may be more responsive to this approach.

MINOR POINTS
1. the cell line should be referred to as LN229 rather than L229.
2. Exposure for the scratch assay shown in figure 2 is very uneven.

ÏÖÓиöÒÉÎÊ.Çë¸ßÖ¸µãÒ»ÏÂÆÀÔÄÈ˵ÄÕ⼸¾ä»°ÓûشðÂð

Reviewer #1: The paper has been clearly improved. However, the effects of bFGF gene silencing on glioma cell proliferation remain rather low.

Reviewer #2: The authors have responded to most of the reviewers comments, but serious reservations remain.
The biggest issue is that the effects observed are fairly modest, and do not provide convincing evidence that this approach will lead anywhere in glioma therapy.

This could potentially be rescued by survival studies, or combinations with chemotherapeutics as suggested in the previous round of comments. The use of glioma stem-like cells may also help, as these may be more responsive to this approach.

»¹ÊÇÖ»»Ø´ðÏÂÃæµÄ¼¸µã¾Í¿ÉÒÔ
Minor point: the authors should label the x-axis of the diagram in Fig. 4.
MINOR POINTS
1. the cell line should be referred to as LN229 rather than L229.
2. Exposure for the scratch assay shown in figure 2 is very uneven.

¸ßÊÖÖ¸µã.лл
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

½ñÌìÀ´¹àË®

Ìú¸Ëľ³æ (Ö°Òµ×÷¼Ò)

¡ï
eveb(½ð±Ò+1,VIP+0):2 10-27 15:20
Ç°ÃæÁ½µãÒ²Òª×ö³ö˵Ã÷»ò½âÊÍ!
2Â¥2009-10-27 12:07:45
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

weiswallow

Ìú¸Ëľ³æ (Ö°Òµ×÷¼Ò)

¡ï
eveb(½ð±Ò+1,VIP+0): 10-27 15:20
²»¹ÜÊÇʲô£¬Ö»ÒªÊÇÉó¸åÒâ¼û£¬¶¼±ØÐëÒªÈÏÕæ»Ø´ðÓë½âÊÍ
ѧÎÞÖ¹¾³
3Â¥2009-10-27 13:54:30
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

liwenbin0929

гæ (ÕýʽдÊÖ)

¡ï
eveb(½ð±Ò+1,VIP+0): 10-27 15:21
Â¥ÉÏÁ½Î»ËµµÄºÜ¶Ô£¬¶ÔÉó¸åÈËÌá³öµÄÒìÒ鱨Ðë×ö»Ø¸´£¬ÒªÐ޸ĵĵط½Ò²¿Ï¶¨ÊÇÒª¸ÄµÄ¡£Ì¬¶È¾ö¶¨Ò»ÇÐ
4Â¥2009-10-27 13:59:05
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

realmadrider

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

¡ï
eveb(½ð±Ò+1,VIP+0): 10-27 15:21
ÒýÓûØÌû:
»¹ÊÇÖ»»Ø´ðÏÂÃæµÄ¼¸µã¾Í¿ÉÒÔ
Minor point: the authors should label the x-axis of the diagram in Fig. 4.
MINOR POINTS
1. the cell line should be referred to as LN229 rather than L229.
2. Exposure for the scratch assay shown in figure 2 is very uneven.

ÕâЩ¶¼ÊÇMINORµÄÎÊÌâ£¬Ç°ÃæµÄ²ÅÊÇMAJORµÄÎÊÌ⣬ºÃºÃ»Ø´ðÉó¸åÈ˵ÄÎÊÌâ
5Â¥2009-10-27 14:22:44
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

awenxm

ÖÁ×ðľ³æ (ÎÄ̳¾«Ó¢)

¡ï
eveb(½ð±Ò+1,VIP+0): 10-27 15:21
¶ÔµÄ£¬ ¶¼Òª»Ø´ð»ò½âÊÍ

¶ÔÓëÇ°ÃæµÄ£¬ÐèÒª½âÊÍһϣ¬
¶ÔÓÚminor pointsÔòÐèÒªÐÞ¸Ä
6Â¥2009-10-27 14:24:13
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ljl8209

ľ³æ (ÖªÃû×÷¼Ò)


¡ï
eveb(½ð±Ò+1,VIP+0): 10-27 21:21
¶¼ÒªÈÏÕæ»Ø´ðµÄ  Ç°ÃæµÄ¸üÖØÒªÒ»Ð©£¬ ºóÃæµÄÓ¦¸ÃÈÝÒ׸㶨
7Â¥2009-10-27 17:09:27
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ eveb µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +18 »ý¼«ÏòÉÏ£» 2026-04-10 20/1000 2026-04-14 16:11 by zs92450
[¿¼ÑÐ] Ò»Ö¾Ô¸»¦9£¬326ÇóÉúÎïѧµ÷¼Á +10 Áõīī 2026-04-13 10/500 2026-04-14 15:16 by zs92450
[¿¼ÑÐ] ¿¼Ñе÷¼Á +13 ³¤¹­°Á 2026-04-13 14/700 2026-04-14 14:44 by zs92450
[¿¼ÑÐ] 305Çóµ÷¼Á +8 Â꿨°Í¿¨boom 2026-04-11 8/400 2026-04-14 09:04 by pengliang8036
[¿¼ÑÐ] »úе¹¤³Ì313·ÖÕÒ¹¤¿Æµ÷¼Á +4 ˫һÁ÷±¾¿Æ»úе 2026-04-08 4/200 2026-04-14 07:32 by Abskk
[¿¼ÑÐ] 293Çóµ÷¼Á +16 ÎÒ°®¸ßÊý¸ßÊý°®Î 2026-04-12 18/900 2026-04-13 21:47 by ѧԱJpLReM
[¿¼ÑÐ] Ò»Ö¾Ô¸211 0703»¯Ñ§ 346·ÖÇóµ÷¼Á +26 ÍÁ¶¹er? 2026-04-09 29/1450 2026-04-13 15:15 by ¶À×íÃι³Ç
[¿¼ÑÐ] 297¹¤¿Æ£¬Çóµ÷¼Á? +13 ºÓÄÏũҵ´óѧ-ÄÜ 2026-04-12 13/650 2026-04-13 14:12 by dingyanbo1
[¿¼ÑÐ] Ò»Ö¾Ô¸Õã´óÉúÎï325·ÖÇóµ÷¼Á +9 zysheng 2026-04-12 9/450 2026-04-12 22:31 by yuyin1233
[¿¼ÑÐ] 291Çóµ÷¼Á +11 ¹ØÒä±±. 2026-04-09 12/600 2026-04-12 10:32 by ÄæË®³Ë·ç
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷±±¹¤Òµ´óѧ289 085602 +33 yangæÃ 2026-04-10 34/1700 2026-04-12 08:11 by Art1977
[¿¼ÑÐ] µ÷¼Á +10 Ö»ÐðÀë±ð´Ç 2026-04-09 12/600 2026-04-11 20:57 by ÄæË®³Ë·ç
[¿¼ÑÐ] 343Çóµ÷¼Á +9 Íõ¹ú˧ 2026-04-10 9/450 2026-04-11 20:31 by dongdian1
[¿¼ÑÐ] 22408 327·ÖÇóµ÷¼Á +4 ÔÏ·çkon 2026-04-10 4/200 2026-04-11 09:51 by Öí»á·É
[¿¼ÑÐ] 337Çóµ÷¼Á +4 ÑÐs. 2026-04-10 4/200 2026-04-11 08:57 by zhq0425
[ÂÛÎÄͶ¸å] mdpiСÐÞrvrʱ¼äËÄÎåÌìÁË 20+3 ¹þ¹þhigh 2026-04-08 5/250 2026-04-10 16:02 by ±±¾©À³ÒðÈóÉ«
[¿¼ÑÐ] Ò»Ö¾Ô¸»ª¶«Ê¦·¶ÉúÎïѧ326·Ö£¬Çóµ÷¼Á +8 Áõīī 2026-04-09 8/400 2026-04-10 12:00 by pengliang8036
[¿¼ÑÐ] 296Çóµ÷¼Á +6 Íô£¡£¿£¡ 2026-04-08 6/300 2026-04-10 11:02 by mattzhming
[¿¼ÑÐ] ²ÄÁÏר˶(0856) 339·ÖÇóµ÷¼Á +9 ¹þ¹þ¹þ¶ì¹þ¹þ¹þ 2026-04-09 10/500 2026-04-09 20:01 by Orcid
[¿¼ÑÐ] 0703»¯Ñ§Çóµ÷¼Á +21 ²»ÖªÃûµÄСئ 2026-04-08 21/1050 2026-04-09 18:55 by l_paradox
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û